Adamas Pharmaceuticals Inc (OQ:ADMS)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for ADMS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET November 22nd, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 8/19 Nov 7/19 Prentiss Christopher B Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 50,000  
Nov 8/19 Nov 7/19 Prentiss Christopher B Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 25,000  
Sep 23/19 Sep 20/19 Merriweather Alfred G Direct Ownership Common Stock S - Open market or private sale -1,584 $6.91
Sep 18/19 Sep 17/19 Mahoney David L Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -33,332  
Sep 18/19 Sep 17/19 Mahoney David L Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 33,332 $1.76
Sep 17/19 Sep 17/19 McFarlane Neil F. Direct Ownership No securities beneficially owned. Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 17/19 Sep 16/19 McFarlane Neil F. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 250,000  
Sep 17/19 Sep 16/19 McFarlane Neil F. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 125,000  
Sep 13/19 Sep 11/19 Mahoney David L Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 40,000  
Jul 23/19 Jul 22/19 Prentiss Christopher B Direct Ownership Common Stock S - Open market or private sale -1,082 $6.00
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ADMS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET November 22nd, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 8/19 Nov 7/19 Prentiss Christopher B Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 50,000  
Nov 8/19 Nov 7/19 Prentiss Christopher B Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 25,000  
Sep 23/19 Sep 20/19 Merriweather Alfred G Direct Ownership Common Stock S - Open market or private sale -1,584 $6.91
Sep 18/19 Sep 17/19 Mahoney David L Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -33,332  
Sep 18/19 Sep 17/19 Mahoney David L Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 33,332 $1.76
Sep 17/19 Sep 16/19 McFarlane Neil F. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 250,000  
Sep 17/19 Sep 16/19 McFarlane Neil F. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 125,000  
Sep 17/19 Sep 17/19 McFarlane Neil F. Direct Ownership No securities beneficially owned. Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 13/19 Sep 11/19 Mahoney David L Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 40,000  
Jul 23/19 Jul 22/19 Prentiss Christopher B Direct Ownership Common Stock S - Open market or private sale -1,082 $6.00
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $ADMS

StockTwits